Clinical Trial Update: Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating arbidol hydrochloride tablets for pneumonia caused by novel coronavirus (2019-nCoV).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia Caused By 2019 Novel Coronavirus

Drugs mentioned

• Arbidol hydrochloride (arbidol hydrochloride)

Snippet

Sponsor: Jieming QU | Conditions: 2019-nCoV | Phase 4 | Status: COMPLETED